All lobbying filings

Becton, Dickinson and Company

Becton, Dickinson and Company filed a Q1 amendment for Becton Dickinson and Company on October 14, 2025.

Lobbying for Becton Dickinson and Company

As filed: BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY.

All filings by Becton, Dickinson and Company · Everything Becton Dickinson and Company has reported

Filing · LD-2 quarterly report Q1 amendment

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Oct 14, 2025

Expenses

$1,438,000

What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization

Trade (domestic/foreign)

Issues related to medical device supply chain

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.